advertisement

---

Dickerson J 10

Showing records 1 to 10 | Display all abstracts from Dickerson J

82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Lass JH
American Journal of Ophthalmology 2019; 208: 211-218

---

82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Reiss G; Clifford B
American Journal of Ophthalmology 2019; 208: 219-225

---

82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Benetz BA; He J
American Journal of Ophthalmology 2019; 208: 211-218

---

82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Vold S
American Journal of Ophthalmology 2019; 208: 219-225

---

82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Hamilton C
American Journal of Ophthalmology 2019; 208: 211-218

---

82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
He J
American Journal of Ophthalmology 2019; 208: 219-225

---

82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Von Tress M
American Journal of Ophthalmology 2019; 208: 211-218

---

82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Hamilton C; Dickerson J
American Journal of Ophthalmology 2019; 208: 219-225

---

82145 Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
Dickerson J; Lane S
American Journal of Ophthalmology 2019; 208: 211-218

---

82148 Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study
Lane S
American Journal of Ophthalmology 2019; 208: 219-225

---